AVAVA has pioneered two devices
Both employ the core enabling Focal Point Technology™ and Intelliview innovation to unlock multiple clinical indications
Both devices are FDA-cleared to deliver 150 mJ via a, non-invasive, breakthrough procedure that promotes skin health, treats skin aging, and can safely treat pigmentary disorders. The design inherent in Focal Point Technology™ spares damage to the epidermis by reducing fluence and allows depth control making it safe for use on all skin colors.
Both devices are FDA-cleared and deliver a, non-invasive, breakthrough procedure that promotes skin health, treats skin aging, and can safely treat pigmentary disorders.
Both devices are FDA-cleared to deliver 150 mJ via a, non-invasive, breakthrough procedure that promotes skin health, treats skin aging, and can safely treat pigmentary disorders. The design inherent in Focal Point Technology™ spares damage to the epidermis by reducing fluence and allows depth control making it safe for use on all skin colors.
Both devices are FDA-cleared and deliver a, non-invasive, breakthrough procedure that promotes skin health, treats skin aging, and can safely treat pigmentary disorders.
Launching 2023for skin health
treatment of skin aging and scars 
|
Launching 2025for pigmentary disorders
Melasma / Hyperpigmentation 
|